Article
AML through the prism of molecular genetics.
British journal of haematology - 1 Jan 2020
Charrot Sarah, Armes Hannah, Rio-Machin Ana, Fitzgibbon Jude
Abstract excerpt
Modern management of acute myeloid leukaemia (AML) relies on the integration of phenotypic and genetic data to assign classification, establish prognosis, enhance monitoring and guide treatment. The prism through which we can now disperse a patient's leukaemia, interpret and apply our understanding has fundamentally changed since the completion of the first whole-genome sequencing (WGS) of an AML patient in 2008...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
